SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,167,000 | +20.7% | 46,400 | 0.0% | 0.09% | -33.3% |
| Q3 2020 | $967,000 | -12.3% | 46,400 | 0.0% | 0.13% | -22.8% |
| Q2 2020 | $1,102,000 | +32.0% | 46,400 | 0.0% | 0.17% | +21.0% |
| Q1 2020 | $835,000 | -69.7% | 46,400 | -60.1% | 0.14% | -73.1% |
| Q4 2019 | $2,756,000 | -13.7% | 116,200 | 0.0% | 0.51% | -19.7% |
| Q3 2019 | $3,193,000 | -17.0% | 116,200 | 0.0% | 0.64% | -41.2% |
| Q2 2019 | $3,845,000 | +18.0% | 116,200 | +24.9% | 1.09% | -6.7% |
| Q1 2019 | $3,259,000 | +68.6% | 93,000 | +59.8% | 1.16% | +18.4% |
| Q4 2018 | $1,933,000 | – | 58,200 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |